The University of Georgia Adoption of Innovative Treatment Techniques in Public and Private Substance Abuse Programs Hannah K. Knudsen, Ph.D. Paul M. Roman,

Slides:



Advertisements
Similar presentations
Role of client early treatment evaluation in post-treatment recovery promoting cognitions and activities A. Laudet, K. Morgen & V. Stanick National Development.
Advertisements

N T C S at UGA * Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation Adoption of Evidence-based Practices in Addiction Treatment.
1 Arlene Ash QMC - Third Tuesday September 21, 2010 (as amended, Sept 23) Analyzing Observational Data: Focus on Propensity Scores.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
Community-based Clinical Trials: Site Variation and Adoption of Innovation Dennis McCarty, PhD Allie Buti, MPH Lynn Kunkel, MS, CCRP Holly Fussell, PhD.
RESEARCH OVERVIEW Traci Rieckmann, Ph.D. OREGON HEALTH AND SCIENCES UNIVERSITY DOUG NOVINS, M.D., UNIVERSITY OF COLORADO DENVER LAURIE MOORE, M.P.H. UNIVERSITY.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
® Introduction Low Back Pain and Physical Function Among Different Ethnicities Adelle A Safo, Sarah Holder DO, Sandra Burge PhD The University of Texas.
Hospitals.
1 Arlene Ash QMC - Third Tuesday September 21, 2010 Analyzing Observational Data: Focus on Propensity Scores.
Instrument Development for a Study Comparing Two Versions of Inquiry Science Professional Development Paul R. Brandon Alice K. H. Taum University of Hawai‘i.
What is Strategy? (Part Two). Key Concepts Managerial Cognition Business Model Stakeholders The Balanced Scorecard.
Clustered or Multilevel Data
Changing times, Changing needs? Library Program Analysis at the Duke University Medical Center Library & UNC Health Science Library Carol Perryman, IMLS/TRLN.
The University of Georgia CTN Membership and Innovation Adoption: Baseline Data from the UGA “Platform” Study NIDA Research Grant R01DA14482 Paul M. Roman,
The University of Georgia Use of ASAM PPC: Data from a National Sample of Addiction Treatment Programs J. Aaron Johnson, PhD The University of Georgia.
S-005 Types of research in education. Types of research A wide variety of approaches: –Theoretical studies –Summaries of studies Reviews of the literature.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.5: Unit 5: Financing Health Care (Part 2) 1.5b: Reimbursement Methodologies and.
Impact of Hospital Provider Payment Mechanism on Household Health Service Utilization in Vietnam (preliminary results) Sarah Bales Public Policy in Asia,
A DOPTION OF E VIDENCE -B ASED P RACTICES IN THE CTN Paul M. Roman & Amanda J. Abraham University of Georgia Presentation at the NIDA Clinical Trials Network.
The University of Georgia Variations in the Adoption of Management Practices Across Types of Substance Abuse Treatment Systems Paul M. Roman Hannah K.
Consumer-Driven Health Plans: Early Evidence about Utilization, Spending and Cost Stephen T Parente Roger Feldman Jon B Christianson October, 2003.
Need and Unmet Need of Mental Health among Community Dwelling Seniors In New York City Shijian Li, Ph.D. SUNY at Old Westbury William Gallo, Ph.D. CUNY.
The University of Georgia Adoption of Medications in Therapeutic Communities: Rates and Organizational Correlates Lori J. Ducharme, Ph.D. Hannah K. Knudsen,
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
The University of Georgia The Treatment of Oxycodone Abuse: Organizational Predictors of Admissions Hannah K. Knudsen Lori J. Ducharme J. Aaron Johnson.
Mental Healthcare Utilization as Adolescents Become Young Adults Jennifer W. Yu, Sc.D. Sally H. Adams, Ph.D. Claire Brindis, Dr.P.H. Charles E. Irwin,
The University of Georgia Racial Disparities in Access to Addiction Treatment Medications Hannah K. Knudsen, Ph.D. Lori J. Ducharme, Ph.D. Paul M. Roman,
The University of Georgia Therapeutic Communities in the USA: A Dynamic Present and a Challenging Future Paul M. Roman, Ph.D. The University of Georgia.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Predictors of Buprenorphine Adoption in Methadone and non- Methadone Treatment Settings Lori J. Ducharme, Ph.D. Hannah K. Knudsen, Ph.D. Paul M. Roman,
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
The University of Georgia Smoking Cessation Programs in Addiction Treatment Centers: An Organizational Analysis Hannah K. Knudsen, Ph.D. Lori J. Ducharme,
Raymond F. Anton, MD for The COMBINE Study Research Group
Differences in the Quality of the Patient- Physician Relationship Among Terminally Ill African American and White Patients: Impact on Advance Care Planning.
Increasing the Relevance of Health Care Organizational Research Jeff Alexander, Ph.D. AHRQ Annual Meeting Sept 8, 2008.
The University of Georgia Trends in Adoption of Medications for Alcohol Dependence Lori J. Ducharme, J. Aaron Johnson, Hannah K. Knudsen & Paul M. Roman.
Copyright © 2014 by Nelson Education Limited. 3-1 Chapter 3 Measures of Central Tendency and Dispersion.
N T C S at UGA * Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation Program Emphasis on Spirituality and Adoption of Evidence-based.
Introduction Results and Conclusions ATR Results: On demographic and social characteristics, ATR completers were more likely to be Hispanic, employed,
1 Presentation to the Academy Health Annual Research Meeting 2006 Brandeis University Schneider Institute for Health Policy June 26, 2006 Research supported.
1- 1 Introduction to US Health Care UUnit 1: The US Health Care System HS230 Health Care Administration Kaplan University Live Seminar Presentation Kathy.
Coverage and Management of Medications for Treating Substance Abuse in Health Plans Constance M. Horgan, Sc.D. Sharon Reif, Ph.D. Dominic Hodgkin, Ph.D.
The University of Georgia
The University of Georgia Training and exposure to evidence-based practices: Changing attitudes among the addiction treatment workforce J. Aaron Johnson,
Relational Discord at Conclusion of Treatment Predicts Future Substance Use for Partnered Patients Wayne H. Denton, MD, PhD; Paul A. Nakonezny, PhD; Bryon.
® Changes in Opioid Use Over One Year in Patients with Chronic Low Back Pain Alejandra Garza, Gerald Kizerian, PhD, Sandra Burge, PhD The University of.
1 Clinical Supervision in the CTN: Availability, Content, and Impact on Counselors Lori J. Ducharme, Hannah K. Knudsen, J. Aaron Johnson & Paul M. Roman.
Counselor Attitudes toward Buprenorphine in the Clinical Trials Network* Hannah K. Knudsen, Ph.D., 1 & Paul M. Roman, Ph.D. 2 1 Department of Behavioral.
Factors Influencing Nursing Home Response to Quality Measure Publication Jacqueline Zinn, Ph.D. Temple University Dana Mukamel, Ph.D. University of California,
SRCC poster template provided by Instructional Resources and Office of Undergraduate Research Comparison of Transition Processes from Secure to Non-secure.
The University of Georgia Different Sectors, Different Services? Examining variations in treatment program caseloads Paul M. Roman, Ph.D. Lori J. Ducharme,
The University of Georgia Wraparound Services in the Public and Private Treatment Sectors: Are Patients Receiving Comprehensive Care? Lori J. Ducharme,
The University of Georgia CTN Membership and Innovation Adoption: Preliminary Data from the UGA “Platform” Study NIDA Research Grant R01DA14482 Paul M.
BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.
Physician Adoption of HIT AHRQ 2007 Annual Meeting September 26, 2007 Melissa M. Goldstein, JD Department of Health Policy School of Public Health and.
A Regional Health Agenda: Opportunities for Collaboration Presentation to the Council of Government’s Health Officers Committee June 11, 2007 Health Working.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Concussion Symptoms in American Football Athletes Kerr ZY, Zuckerman SL, Wasserman.
Evaluation of P.H.C. services by Prof.Dr. Sabry Ahmed Salem. Prof. of community, Environmental and occupational medicine.
Chapter 14 Measurement and Evaluation. Chapter Objectives 1.Explain the importance of continuous measurement and evaluation of facility and event organizations.
Acknowledgments: Craig Ravesloot, PhD., Tannis Hargrove, MS, The Rural Institute, University of Montana. Introduction, Materials, and Methods In this study.
Symposium CLIENT –PROVIDER RELATIONSHIP AS AN ACTIVE INGREDIENT IN DELIVERY OF SOCIAL SERVICES Organizer: Jeanne C. Marsh, PhD, MSW University of Chicago.
Approaches to Linking Process and Outcome Data in a Cross-Site Evaluation Laura Elwyn, Ph.D. Kristin Stainbrook, Ph.D. American Evaluation Association.
J. Aaron Johnson, Ph.D. Lori J. Ducharme, Ph.D. Sarah Henderson, M.A.
Chapter 41 Health Care Delivery Systems and Financing Issues
Trena M. Ezzati-Rice, Frederick Rohde, Robert Baskin
Component 1: Introduction to Health Care and Public Health in the U.S.
Rosemary White-Traut, PhD, RN, FAAN
Introduction to Health Service Organizations
A Training For Multidisciplinary Addiction Professionals
Presentation transcript:

The University of Georgia Adoption of Innovative Treatment Techniques in Public and Private Substance Abuse Programs Hannah K. Knudsen, Ph.D. Paul M. Roman, Ph.D. Meredith Huey, M.A. Center for Research on Behavioral Health and Human Services Delivery American Public Health Association, November 2004

The University of Georgia The “Research to Practice” Gap There is ongoing concern in the substance abuse treatment field that the pace of innovation adoption is slow A growing literature is beginning to examine the organizational predictors of innovation adoption in these healthcare settings Key gaps in the research literature include: –Comparisons of public & private treatment facilities –Applications of broader organizational theory in this context –Consideration of both aggregate innovativeness as well as the processes underlying the adoption of specific innovations

The University of Georgia Organizational Research on Innovation Adoption In the larger literature, most research focuses on individual innovations –Substance abuse treatment literature follows this pattern— adoption of specific techniques, attitudes toward a given innovation, technology transfer within an organization Rogers’ concept of “organizational compatibility” is useful in understanding the adoption of particular innovations –There needs to be a “fit” between the characteristics of a given innovation and the organization’s culture & structural resources The emphasis on individual innovations complicates the development of general theory about innovation adoption

The University of Georgia Aggregate Innovation Some organizational theorists have called for research on aggregate measures of innovativeness –Such a measure usually involves an additive count of the number of innovations adopted The goal of such research is to identify the broader organizational & managerial processes that increase an organization’s propensity to adopt innovations It allows for the development of theory that addresses the variation in innovation adoption

The University of Georgia Aggregate Innovation and Absorptive Capacity Cohen & Levinthal (1990) define “absorptive capacity” as the extent to which an organization can procure, process, & assimilate information Three organizational behaviors that indicate greater absorptive capacity: –The employment of a professional workforce –Environmental scanning (the use of external sources of information, e.g. journals, professional development) –Collection of satisfaction data from organizational “buyers” and suppliers” (i.e. gathering information about unmet needs that could be addressed with innovations)

The University of Georgia Absorptive Capacity: Applications in Substance Abuse Treatment Organizations Absorptive capacity may be a key organizational resource that can support the adoption of innovations To date, absorptive capacity and aggregate innovation has only been examined in private treatment organizations (Knudsen & Roman, 2004) –It is unclear if the utility of this construct generalizes to the public sector It is less clear if absorptive capacity will also have applicability to specific treatment innovations

The University of Georgia Research Questions Is there variation in aggregate innovation across government-owned, public non-profits, private non- profits, and for-profits? Does absorptive capacity predict aggregate innovation in a sample of public & private treatment facilities? Is absorptive capacity associated with the adoption of specific innovations? –Buprenorphine –Naltrexone –Motivational incentives/vouchers (a.k.a. contingency management)

The University of Georgia Methods Nationally representative samples of publicly funded and private funded substance abuse treatment facilities (n = 746) Dependent variables –Aggregate Innovation: sum of 14 techniques (4 medications and 9 psycho-social techniques)  Mean = 4.60 (SD = 2.69) –Buprenorphine Adoption: dichotomous measure of center currently uses vs. does not use  10.0% have adopted –Naltrexone Adoption: dichotomous measure of center currently uses vs. does not use  30.4% have adopted –Motivational Incentives Adoption: dichotomous measure of center currently uses vs. does not use  25.4% have adopted

The University of Georgia Methods (continued) Absorptive Capacity Workforce professionalism –% Master’s-level counselors –% counselors in recovery –Physician resources (doctors on payroll, contract doctors, no doctors as reference category) Environmental Scanning: additive index of five items of use of external information sources Collection of Satisfaction Data: sum of two items measuring data collected from referral sources & third party payers

The University of Georgia Methods (continued) Organizational Characteristics –Center type: government-owned, publicly funded non-profit, for-profit, privately funded non-profit (reference category) –Size: natural log-transformed number of employees –Age: natural log-transformed years –Rural location: center in non-MSA county vs. center in MSA county –Levels of care: inpatient-only, mixed inpatient & outpatient, outpatient-only (reference category)

The University of Georgia Negative Binomial Regression: Aggregate Innovation % Change in Expected Count % Change in Expected Count Government-Owned-21.6%NS Publicly Funded Non-Profit-25.0%-12.3% For-Profit-13.7%NS Size-----NS Age-----NS Rural-----NS Inpatient-only % Mixed IP & OP % % Master’s Counselors % % Recovering Counselors-----NS Doctor On-Staff % Contract Physician % Environmental Scanning % Collection of Satisfaction Data %

The University of Georgia Logistic Regression: Buprenorphine Adoption Odds Ratio Government-Owned Publicly Funded Non-Profit For-ProfitNS Size-----NS Age-----NS Rural-----NS Inpatient-only-----NS Mixed IP & OP % Master’s Counselors-----NS % Recovering Counselors-----NS Doctor On-Staff Contract Physician-----NS Environmental Scanning-----NS Collection of Satisfaction Data

The University of Georgia Logistic Regression: Naltrexone Adoption Odds Ratio Government-Owned Publicly Funded Non-Profit For-ProfitNS Size-----NS Age-----NS Rural-----NS Inpatient-only-----NS Mixed IP & OP % Master’s Counselors % Recovering Counselors-----NS Doctor On-Staff Contract Physician-----NS Environmental Scanning Collection of Satisfaction Data (p=.06)

The University of Georgia Logistic Regression: Motivational Incentives Adoption Odds Ratio Government-Owned Publicly Funded Non-Profit For-Profit.501 (p=.052).449 Size-----NS Age Rural-----NS Inpatient-only-----NS Mixed IP & OP-----NS % Master’s Counselors-----NS % Recovering Counselors-----NS Doctor On-Staff-----NS Contract Physician-----NS Environmental Scanning-----NS Collection of Satisfaction Data-----NS

The University of Georgia Summary: Innovation & Center Type Innovation adoption varied by center type Privately funded non-profits scored highest in aggregate innovation, while publicly funded non- profits were the lowest –These differences largely mediated by absorptive capacity & organizational characteristics Private sector more likely to adopt buprenorphine & naltrexone than public sector Public sector more likely to adopt motivational incentives –These differences persisted after controlling for absorptive capacity & organizational characteristics

The University of Georgia Summary: Absorptive Capacity Measures of absorptive capacity worked well in the model of aggregate innovation –Workforce professionalism, environmental scanning, and collection of satisfaction data all significantly associated with aggregate innovation, net of organizational characteristics Absorptive capacity less useful in predicting adoption of specific innovations –Modest support for buprenorphine, clearer support for naltrexone, and no support for motivational incentives Models of organizational compatibility—that look at “fit” between innovation’s characteristics and the organization’s culture/structure—may be more predictive of the adoption of specific innovations

The University of Georgia Acknowledgements This research was supported by the National Institute on Drug Abuse (R01-DA and R01-DA-14482). More information about the National Treatment Center Study can be found online at